Home RxNorm 2468237 DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2468237
RxNorm name DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe
Display name DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe
Full name DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe
Term type PSN
Status DailyMed mapping
Updated 2026-06-04 23:38:55 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125563 Vaxelis Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine 351(a) Rx 2026-08-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 3ed8472a-c6eb-4076-9d66-025ede589e3d DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe [PSN] · 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vac [SCD] · DTap-IPV-Hib-HepB 0.5 ML Prefilled Syringe [SY] 3 14 These highlights do not include all the information needed to use VAXELIS safely and effectively. See full prescribing information for VAXELIS. VAXELIS ® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) injectable suspension, for intramuscular use Initial U.S. Approval: 2018 20260428 174faf80-eb4f-4f11-b875-d74bd26c2e65 DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe [PSN] · 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vac [SCD] · DTap-IPV-Hib-HepB 0.5 ML Prefilled Syringe [SY] 3 1 These highlights do not include all the information needed to use VAXELIS safely and effectively. See full prescribing information for VAXELIS. VAXELIS ® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) Suspension for Intramuscular Injection Initial U.S. Approval: 2018 20250513